Ionis Pharmaceuticals, Inc.
IONS NASDAQHealthcare ★★★★★Latest Earnings Above forecast↑
Date
Jul 29, 2026
ET
EPS Est.
-1.08
EPS Actual
-0.69
Revenue Est.
$189.1M
Revenue Actual
$268M
Next Earnings Report
Date
Nov 4, 2026 · Wed
Time
Pre-market
Fiscal Period
FY2026 Q3
EPS Est.
-1.22
Revenue Est.
$181.8M
Company Overview
Ionis Pharmaceuticals, Inc. (ticker IONS) is listed on NASDAQ with a market cap of about $9.93B. Its next earnings report (FY2026 Q3) is expected on Nov 4, 2026 (ET), Pre-market, with consensus EPS of -1.22. In the last 15 reported quarters, EPS beat consensus estimates 14 times.
Actual EPS TrendRecently15Term · Feb 22, 2023 → Jul 29, 2026
Feb 22, 2023Range: -1.41 ~ 0.86Jul 29, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 29, 2026 | -- | -1.08 | Above forecast↑-0.69 | $189.1M | $268M |
| Apr 29, 2026 | -- | -0.85 | Above forecast↑-0.56 | $195.6M | $246M |
| Feb 25, 2026 | -- | -1.24 | -1.41 | $156.1M | $203M |
| Oct 29, 2025 | -- | -1.15 | Above forecast↑-0.61 | $153.6M | $156.7M |
| Jul 30, 2025 | -- | 0.27 | Above forecast↑0.86 | $131.7M | $452M |
| Apr 30, 2025 | -- | -1.11 | Above forecast↑-0.75 | $150.6M | $131.6M |
| Feb 19, 2025 | -- | -1.09 | Above forecast↑-0.66 | $131.1M | $226.6M |
| Nov 6, 2024 | -- | -1.16 | Above forecast↑-0.95 | $144.4M | $133.8M |
| Aug 1, 2024 | -- | -0.92 | Above forecast↑-0.45 | $150.1M | $225.3M |
| May 7, 2024 | -- | -1.05 | -0.98 | $131.4M | $119M |
| Feb 21, 2024 | -- | -0.83 | Above forecast↑-0.06 | $174.8M | $324.5M |
| Nov 2, 2023 | -- | -1.04 | -1.03 | $132.9M | $144.2M |
| Aug 9, 2023 | -- | -0.90 | Above forecast↑-0.60 | $138.8M | $188.4M |
| May 3, 2023 | -- | -0.91 | -0.87 | $140.5M | $130.5M |
| Feb 22, 2023 | -- | -1.06 | Above forecast↑-0.37 | $160.1M | $151.9M |
Original Filings (SEC)
10-Q2026-07-29 ↗
8-K2026-07-29 ↗
8-K2026-07-10 ↗
8-K2026-07-09 ↗
8-K2026-06-24 ↗
8-K2026-06-12 ↗
8-K2026-06-08 ↗
8-K2026-05-28 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
